The Rapid Growth of CRISPR Startup Mammoth Biosciences
Biotech startup Mammoth Biosciences โofficially achieved โunicornโ status in September 2021. After securing US$195 million in funding, it now has a total valuation of more than US$1 billion.
The financing for the California-based company comprises a US$150 million in its Series D round, following a $45 million in Series C funding in late 2020 led by venture capitals and investment firms.
The Rapid Growth of CRISPR Startup Mammoth Biosciences Read More ยป
Biotech startup Mammoth Biosciences โofficially achieved โunicornโ status in September 2021. After securing US$195 million in funding, it now has a total valuation of more than US$1 billion.
The financing for the California-based company comprises a US$150 million in its Series D round, following a $45 million in Series C funding in late 2020 led by venture capitals and investment firms.















